Association of Pharmaceutical Industry Marketing of Opioid Products to Physicians With Subsequent Opioid Prescribing. | |
Hadland Scott E; Cerdá Magdalena; Li Yu; Krieger Maxwell S; Marshall Brandon D L | |
刊名 | JAMA INTERNAL MEDICINE JAMA INTERNAL MEDICINE |
2018 | |
卷号 | Vol.178 No.6页码:861-863 |
ISSN号 | 2168-6114 |
URL标识 | 查看原文 |
公开日期 | [db:dc_date_available] |
内容类型 | 期刊论文 |
URI标识 | http://www.corc.org.cn/handle/1471x/5465334 |
专题 | 湖南大学 |
作者单位 | Grayken Center for Addiction, Boston Medical Center, Boston, Massachusetts. Department of Pediatrics, Boston Medical Center, Boston, Massachusetts. Division of General Pediatrics, Department of Pediatrics, Boston University School of Medicine, Boston, Massachusetts. Department of Emergency Medicine, School of Medicine, University of California at Davis, Sacramento, California. Department of Epidemiology, Brown University School of Public Health, Providence, Rhode Island. Department of Epidemiology, Brown University School of Public Health, Providence, Rhode Island. Department of Epidemiology, Brown University School of Public Health, Providence, Rhode Island. |
推荐引用方式 GB/T 7714 | Hadland Scott E,Cerdá Magdalena,Li Yu,et al. Association of Pharmaceutical Industry Marketing of Opioid Products to Physicians With Subsequent Opioid Prescribing.[J]. JAMA INTERNAL MEDICINE JAMA INTERNAL MEDICINE,2018,Vol.178 No.6:861-863. |
APA | Hadland Scott E,Cerdá Magdalena,Li Yu,Krieger Maxwell S,&Marshall Brandon D L.(2018).Association of Pharmaceutical Industry Marketing of Opioid Products to Physicians With Subsequent Opioid Prescribing..JAMA INTERNAL MEDICINE JAMA INTERNAL MEDICINE,Vol.178 No.6,861-863. |
MLA | Hadland Scott E,et al."Association of Pharmaceutical Industry Marketing of Opioid Products to Physicians With Subsequent Opioid Prescribing.".JAMA INTERNAL MEDICINE JAMA INTERNAL MEDICINE Vol.178 No.6(2018):861-863. |
个性服务 |
查看访问统计 |
相关权益政策 |
暂无数据 |
收藏/分享 |
除非特别说明,本系统中所有内容都受版权保护,并保留所有权利。
修改评论